CEA is a protein normally not detected in the blood of a healthy person. When certain types of cancer are present, CEA may be produced by the cancer cells. CEA may then be detected in blood, but it will not indicate which kind of cancer is present. CEA is often used to monitor patients with cancers of the gastrointestinal (GI) tract such as bowel (colorectal) cancer. It may be raised in other cancers, such as ovarian and breast cancers, but can also be raised in benign conditions such as liver disease and inflammatory bowel disease (Crohns disease or ulcerative colitis).
Bowel cancer tumour marker
£105.80
In the presence of certain cancers, including bowel cancer, Carcino Embryonic Antigen (CEA) may be used to monitor the effect of treatment and recurrence of disease. There are pros and cons to doing such a test and it is really important that before doing any genetic/cancer monitoring/predicting test, you speak to a clinician to determine if this is the right test for your, and how to manage the results.
Est. Result Turnaround Time : 4 hours
